Estudo randomizado | Patiromer para tratamento de hiperpotassemia na insuficiência cardíaca com fração de ejeção reduzida.

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial – European Society of Cardiology

Comentário no Twitter

No one wants to add meds just so you can add more meds. BUT, adding patiromer in select patients with HFrEF so you can optimize GDMT sure is compelling… 🤔 https://t.co/79gSEwon4y

— ATRIUM Cardiology (@ATRIUMRx) July 29, 2022